688336.SH
三生国健
SSE · Healthcare · Biotechnology · CN
CNY 43.45
−8.81%Margins
Gross margin
92.1%
EBITDA margin
79.9%
EBIT margin
79.0%
Net margin
68.9%
FCF margin
58.5%
34.5%
Return on equity
33.2%
Return on assets
—
Return on invested capital
0.48x
Asset turnover
CNY 2.8B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026